1. 1. Notwithstanding the uniformity of treatment requirements of section 514C.6, a contract, policy, or plan providing for third-party payment or prepayment for cancer treatment shall not discriminate between coverage benefits for prescribed, orally administered anticancer medication used to kill or slow the growth of cancerous cells and intravenously administered or injected cancer medications that are covered, regardless of formulation or benefit category determination by the contract, policy, or plan.

2. 2. The provisions of this section shall apply to all of the following classes of third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after July 1, 2009:

   1. a. Individual or group accident and sickness insurance providing coverage on an expense-incurred basis.
   2. b. An individual or group hospital or medical service contract issued pursuant to chapter 509, 514, or 514A.
   3. c. An individual or group health maintenance organization contract regulated under chapter 514B.
   4. d. An individual or group Medicare supplemental policy, unless coverage pursuant to such policy is preempted by federal law.
   5. e. A plan established pursuant to chapter 509A for public employees.
3. 3. This section shall not apply to accident-only, specified disease, short-term hospital or medical, hospital confinement indemnity, credit, dental, vision, long-term care, basic hospital, and medical-surgical expense coverage as defined by the commissioner, disability income insurance coverage, coverage issued as a supplement to liability insurance, workers’ compensation or similar insurance, or automobile medical payment insurance.
4. 4. The commissioner of insurance shall adopt rules pursuant to chapter 17A as necessary to administer this section.

2009 Acts, ch 179, §183